Fungal Isolates of the Respiratory Tract in Symptomatic Patients Hospitalized in Pulmonary Units: A Mycological and Molecular Epidemiologic Study

References

• Fauci AS, Morens DM. The perpetual challenge of infectious diseases. N Engl J Med. 2012;366(5):454–461. doi:10.1056/NEJMra1108296
   PubMed Web of Science ®Google Scholar
• Brown GD, Denning DW, Gow NA, et al. Hidden killers: human fungal diseases. Sci Transl Med. 2012;4(165):165rv13. doi:10.1126/scitranslmed.3004404
   PubMed Web of Science ®Google Scholar
• Ben-Ami R, Lewis RE, Kontoyiannis DP. Invasive mould diseases in the setting of hematopoietic cell transplantation: current trends and new challenges. Curr Opin Infect Dis. 2009;22(4):376–384. doi:10.1097/QCO.0b013e32832db9f3
   Web of Science ®Google Scholar
• Aimanianda V, Bayry J, Bozza S, et al. Surface hydrophobin prevents immune recognition of airborne fungal spores. Nature. 2009;460(7259):1117–1121. doi:10.1038/nature08264
   PubMed Web of Science ®Google Scholar
• Panda B. Fungal diseases of lungs: the emerging scenario. Indian J Tubercul. 2004;51(2):63–70.
   Google Scholar
• Wilson LS, Reyes CM, Stolpman M, Speckman J, Allen K, Beney J. The direct cost and incidence of systemic fungal diseases. Value Health. 2002;5(1):26–34. doi:10.1046/j.1524-4733.2002.51108.x
   PubMed Web of Science ®Google Scholar
• Kubak BM. Fungal infection in lung transplantation. Transpl Infect Dis. 2002;4(3):24–31. doi:10.1034/j.1399-3062.4.s3.4.x
   Google Scholar
• Pagano L, Caira M, Fianchi L. Pulmonary fungal infection with yeasts and pneumocystis in patients with hematological malignancy. Ann Med. 2005;37(4):259–269. doi:10.1080/07853890510037374
   PubMed Web of Science ®Google Scholar
• Sole A, Morant P, Salavert M, et al. Aspergillus infections in lung transplant recipients: risk factors and outcome. Clin Microbiol Infect. 2005;11(5):359–365. doi:10.1111/j.1469-0691.2005.01128.x
   Web of Science ®Google Scholar
• Tripathy U, Yung GL, Kriett JM, Thistlethwaite PA, Kapelanski DP, Jamieson SW. Donor transfer of pulmonary coccidioidomycosis in lung transplantation. Ann Thorac Surg. 2002;73(1):306–308. doi:10.1016/S0003-4975(01)02723-0
   Web of Science ®Google Scholar
• Hageage GJ, Harrington BJ. Use of calcofluor white in clinical mycology. Lab Med. 1984;15(2):109–112. doi:10.1093/labmed/15.2.109
   Google Scholar
• Cheesbrough M. District Laboratory Practice in Tropical Countries. 2th ed. Cambridge university press; 2006.
   Google Scholar
• Lai -C-C, Hsu HL, Lee LN, Hsueh P-R. Assessment of Platelia Aspergillus enzyme immunoassay for the diagnosis of invasive aspergillosis. J Microbiol Immunol Infect. 2007;40(2):148–153.
   Google Scholar
• Abe M, Ogawa Z, Tanuma H, Kume H. Study of mycological examination methods in clinical laboratories-specimen pretreatment and isolation. Jpn J Med Mycol. 2009;50(4):235–242. doi:10.3314/jjmm.50.235
   Google Scholar
• Procop GW, Church D, Hall G, et al. Koneman’s Color Atlas and Textbook of Diagnostic Microbiology. 7th ed. Philadelphia: Wolters Kluwer; 2017.
   Google Scholar
• Agarwal S, Manchanda V, Verma N, Bhalla P. Yeast identification in routine clinical microbiology laboratory and its clinical relevance. Indian J Med Microbiol. 2011;29(2):172–177. doi:10.4103/0255-0857.81794
   PubMed Web of Science ®Google Scholar
• Topely & Wilsons. Microbiology and Microbial Diseases. 10th ed. Hodder Arnold Publisher; 2005.
   Google Scholar
• Badiee P. Evaluation of human body fluids for the diagnosis of fungal diseases. Biomed Res Int. 2013;2013.
   Web of Science ®Google Scholar
• Nasri T, Hedayati MT, Abastabar M, et al. PCR-RFLP on β-tubulin gene for rapid identification of the most clinically important species of Aspergillus. J Microbiol Method. 2015;117:144–147. doi:10.1016/j.mimet.2015.08.007
   Web of Science ®Google Scholar
• Ferrer C, Colom F, Frasés S, Mulet E, Abad JL, Alio JL. Detection and identification of fungal pathogens by PCR and by ITS2 and 5.8 S ribosomal DNA typing in ocular infections. J Clin Microbiol. 2001;39(8):2873–2879. doi:10.1128/JCM.39.8.2873-2879.2001
   Web of Science ®Google Scholar
• Donnelly JP, Chen SC, Kauffman CA, et al. Revision and update of the consensus definitions of invasive fungal disease from the European Organization for research and treatment of cancer and the mycoses study group education and research Consortium. Clin Infect Dis. 2019. doi:10.1093/cid/ciz1008
   PubMed Web of Science ®Google Scholar
• Jahromi SB, Khaksar AA. Fungal isolates of the respiratory tract. Crit Care Med. 2002;30(12):A111. doi:10.1097/00003246-200212001-00378
   Web of Science ®Google Scholar
• Akhtar A, Roohani AH, Fatima N, Shameem M, Khan HM, Khan PA. Comparing the profile of respiratory fungal pathogens amongst immunocompetent and immunocompromised hosts, their susceptibility pattern and correlation of various opportunistic respiratory fungal diseases and their progression in relation to the CD4+ T-cell counts. Indian J Med Microbiol. 2018;36(3):408.
   Web of Science ®Google Scholar
• Ahmed M, Farghaly A, Raafat R, Abd Elsattar W. Study of the prevalence and pattern of fungal pneumonias in respiratory intensive care unit. Egypt J Bronchol. 2019;13(4):545–550. doi:10.4103/ejb.ejb_37_19
   Google Scholar
• Gavazzi G, Krause K-H. Ageing and disease. Lancet Infect Dis. 2002;2(11):659–666. doi:10.1016/S1473-3099(02)00437-1
   PubMed Web of Science ®Google Scholar
• Rafiee S, Besharat S, Jabbari A, Golalipour F, Nasermoaadeli A. Epidemiology of tuberculosis in northeast of Iran: a population-based study. Iran J Med Sci. 2009;34(3):193–197.
   Google Scholar
• Fontalvo DM, Jiménez Borré G, Gómez Camargo D, et al. Tuberculosis and fungal co-disease present in a previously healthy patient. Colomb Med. 2016;47(2):105–108. doi:10.25100/cm.v47i2.2271
   Web of Science ®Google Scholar
• Joos L, Tamm M. Breakdown of pulmonary host defense in the immunocompromised host: cancer chemotherapy. Proc Am Thorac Soc. 2005;2(5):445–448. doi:10.1513/pats.200508-097JS
   Google Scholar
• Ramirez LC, Dal Nogare A, Hsia C, et al. Relationship between diabetes control and pulmonary function in insulin-dependent diabetes mellitus. Am J Med. 1991;91(4):371–376. doi:10.1016/0002-9343(91)90154-P
   Web of Science ®Google Scholar
• Spahr J, Weiner DJ, Stokes DC, Kurland G. Pulmonary Disease in the pediatric patient with acquired immunodeficiency states. In: Kendig’s Disorders of the Respiratory Tract in Children. Elsevier; 2019:923–943.
   Google Scholar
• Hedayati MT, Mayahi S, Denning DW. A study on Aspergillus species in houses of asthmatic patients from Sari city, Iran and a brief review of the health effects of exposure to indoor Aspergillus. Environ Monit Assess. 2010;168(1–4):481–487. doi:10.1007/s10661-009-1128-x
   Web of Science ®Google Scholar
• Hedayati MT, Mayahi S, Movahedi M, Shokohi T. A Study on fungal flora of tap water as a potential reservoir of fungi in hospitals from Sari city, Iran. J Mycol Méd. 2011;21(1):10–14. doi:10.1016/j.mycmed.2010.12.001
   Web of Science ®Google Scholar
• Zarrinfar H, Saber S, Kordbacheh P, et al. Mycological microscopic and culture examination of 400 Bronchoalveolar Lavage (BAL) samples. Iran J Public Health. 2012;41(7):70–76.
   PubMed Web of Science ®Google Scholar
• Zanganeh E, Zarrinfar H, Rezaeetalab F, et al. Predominance of non-fumigatus Aspergillus species among patients suspected of pulmonary aspergillosis in a tropical and subtropical region of the Middle East. Microb Pathog. 2018;116:296–300. doi:10.1016/j.micpath.2018.01.047
   PubMed Web of Science ®Google Scholar
• Hedayati MT, Khodavaisy S, Alialy M, Omran SM, Habibi MR. Invasive aspergillosis in intensive care unit patients in Iran. Acta Medica (Hradec Kralove). 2013;56(2):52–56. doi:10.14712/18059694.2014.24
   PubMedGoogle Scholar
• Clancy CJ, Jaber RA, Leather LH, et al. Bronchoalveolar lavage galactomannan in diagnosis of invasive pulmonary aspergillosis among solid-organ transplant recipients. J Clin Microbiol. 2007;45:1759–1765.
   PubMed Web of Science ®Google Scholar
• Husain S, Clancy CJ, Nguyen MH, et al. Performance characteristics of the Platelia Aspergillus enzyme immunoassay for detection of Aspergillus galactomannan antigen in bronchoalveolar lavage fluid. Clin Vaccine Immunol. 2008;15(12):1760–1763. doi:10.1128/CVI.00226-08
   Google Scholar
• Sanguinetti M, Posteraro B, Pagano L, et al. Comparison of real-time PCR, conventional PCR, and galactomannan antigen detection by enzyme- linked immunosorbent assay using bronchoalveolar lavage fluid samples from hematology patients for diagnosis of invasive pulmonary aspergillosis. J Clin Microbiol. 2003;41:3922–3925. doi:10.1128/JCM.41.8.3922-3925.2003
   PubMed Web of Science ®Google Scholar
• Kali A, Charles MP, Noyal MJ, Sivaraman U, Kumar S, Easow JM. Prevalence of Candida co-infection in patients with pulmonary tuberculosis. Australas Medical J. 2013;6(8):387–391. doi:10.4066/AMJ.2013.1709
   Google Scholar
• Denning DW, Pleuvry A, Cole DC. Global burden of chronic pulmonary aspergillosis as a sequel to pulmonary tuberculosis. Bull World Health Organ. 2011;89(12):864–872. doi:10.2471/BLT.11.089441
   PubMed Web of Science ®Google Scholar